Anti-Human FCGR2B Antibody [B232]
Anti-Human FCGR2B Antibody [B232] with collaborator-tested evidence for WB, IHC-P. Read more ›
["WBProduct Description
FCGR2B is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: B232; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IHC-P. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human CD32b protein; purification: Protein A; concentration: 1 mg/mL.
Database references: UniProt: P31994.
Research Use Only.
Key Facts
| Target | FCGR2B |
| Also known as | FCG, CDw, Fcgr, IGFR, FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2, CDw32, Fc-gamma-RIIb, FcRII-b, Low affinity immunoglobulin gamma Fc region receptor II-b, IgG Fc receptor II-b, Fc-gamma RII-b, CD32 antigen, Fc fragment of IgG, Fc gamma receptor IIB, Fc gamma RII, Fc gamma RIIB, FCG2B, Fc-gamma RII, FCRII, FcγRⅡ, IgG Fc receptor II beta, low affinity II, low affinity IIb, Low affinity immunoglobulin gamma Fc region receptor II, Ly-17, Lym 1, Lymphocyte antigen 17, receptor, receptor (CD32), receptor for, receptor for (CD32) |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Observed band | 38 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Immunology, Stem Cells |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.